Compositions and methods are provided for treating viral infection in a mammalbyadministering a therapeutic dose of a pharmaceutical composition that inhibitsAXL, MER orTyro3 protein activity, for example by inhibition of the binding interactionbetween AXL, MER orTyro3 and its ligand GAS6.